On February 8, Novo sent a formal demand letter to HIMS to cease the manufacturing and sale of unapproved compounded versions of its weight-loss drug Wegovy
The WHO defines obesity as a BMI greater than or equal to 30 for adults
Common, harmless side effects Water retention (GH peptides): Mild puffiness, especially in hands/feet Temporary (resolves within weeks) Not dangerous Reduce dose if bothersome Injection site reactions: Slight redness or bump at injection site Temporary Rotate sites to minimize Not concerning unless severe Initial fatigue (GH peptides): First 1-2 weeks Body adjusting to increased GH Improves with time Take peptides before bed Increased hunger (GHRP-6): Expected with GHRP-6 Manage with meal timing Switch to Ipamorelin if problematic These are normal and not cause for alarm
Animal studies have demonstrated effects on gastric function, gut-brain signaling, and inflammatory pathways that overlap with some GLP-1 mechanisms
When to Talk to Your Licensed Healthcare Provider Before starting the Wegovy pill, consider addressing these questions with your licensed healthcare provider: Ask: I take [medication name]
The medications are more likely to be covered for treatment of diabetes than when prescribed off-label for weight loss, says Banini
